Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03511495 · ClinicalTrials.gov registry record
Reliability of Topography Measurements in Keratoconus
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 86
- Enrollment target
NCT03511495: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT03511495 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03511495 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the reliability and repeatability of the parameters obtained using the Galilei dual-scheimpflug corneal topographer for monitoring progression in eyes with keratoconus.
Primary Outcome
Assessment of the steepness of the cornea
Interventions
- DIAGNOSTIC_TEST Galilei Corneal Topographer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2019-03-31 |
What the finished NCT03511495 record still lists
NCT03511495 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Galilei Corneal Topographer is the first listed.
NCT03511495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03511495 about?
NCT03511495 is a clinical study titled "Reliability of Topography Measurements in Keratoconus". The purpose of this study is to assess the reliability and repeatability of the parameters obtained using the Galilei dual-scheimpflug corneal topographer for monitoring progression in eyes with keratoconus.
What is the current status of trial NCT03511495?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2017-09-11. Estimated completion is 2019-03-31.
What interventions are being tested in trial NCT03511495?
The interventions under investigation include: Galilei Corneal Topographer (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03511495?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI